QIAGEN Gaithersburg, Inc
36
1
3
26
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
6 terminated/withdrawn out of 36 trials
81.3%
-5.3% vs industry average
0%
0 trials in Phase 3/4
27%
7 of 26 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (36)
Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel Plus
Role: lead
Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR
Role: lead
QIAstat-Dx® BCID Plus AMR Panels Clinical Performance Study
Role: lead
DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit
Role: lead
QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001
Role: lead
Therascreen® KRAS RGQ PCR Kit
Role: lead
Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 Assay
Role: lead
Clinical Evaluation of the NeuMoDx SARS-CoV-2 Assay (COVID-19)
Role: lead
Clinical Performance of QIAstat-Dx® Gastrointestinal Panel 2
Role: lead
Clinical Performance Evaluation of the NeuMoDx™ EBV Quant Assay 2.0 in Immunocompromised Transplant Patients
Role: lead
Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit
Role: lead
Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit
Role: lead
Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit
Role: lead
QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study
Role: lead
Impact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community-acquired Pneumonia in the Emergency Room
Role: collaborator
QIAstat-Dx® Respiratory Panel Plus (RPP) Clinical Performance Study
Role: lead
VascuFit: Exercise and Vascular Aging
Role: collaborator
cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project
Role: collaborator
Prediction of Spontaneous Onset of Labor at Term
Role: collaborator
QuantiFERON Access Clinical Performance Study Protocol
Role: lead